1. Home
  2. DCBO vs IVVD Comparison

DCBO vs IVVD Comparison

Compare DCBO & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Docebo Inc.

DCBO

Docebo Inc.

HOLD

Current Price

$19.71

Market Cap

489.9M

Sector

N/A

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.46

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCBO
IVVD
Founded
2016
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
489.9M
437.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
DCBO
IVVD
Price
$19.71
$1.46
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$32.00
$8.75
AVG Volume (30 Days)
215.2K
1.9M
Earning Date
05-08-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.02
EPS
N/A
N/A
Revenue
N/A
$53,426,000.00
Revenue This Year
$12.54
$143.48
Revenue Next Year
$11.82
$25.40
P/E Ratio
$22.04
N/A
Revenue Growth
N/A
110.47
52 Week Low
$16.07
$0.46
52 Week High
$33.69
$3.07

Technical Indicators

Market Signals
Indicator
DCBO
IVVD
Relative Strength Index (RSI) 53.28 34.31
Support Level $18.11 $1.41
Resistance Level $20.15 $2.00
Average True Range (ATR) 0.97 0.13
MACD 0.18 -0.02
Stochastic Oscillator 46.83 1.83

Price Performance

Historical Comparison
DCBO
IVVD

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: